Share Print

Treating Neurofibromatosis Type II (NF2)

         

Dec. 23, 2010 – Washington University physicians at the Siteman Cancer Center are forming a comprehensive center for the treatment of neurofibromatosis type 2 (NF2). NF2 is a hereditary disease that often results in multiple brain and spinal tumors. In this Cancer Connection podcast, Siteman neurosurgeon Michael Chicoine, MD, discusses the symptoms of NF2 , treatment and the new NF2 center. According to Chicoine, there are only two other comprehensive NF2 centers in the country, one in Los Angeles and one in Boston. 

Related Content: